✦ LIBER ✦

CE4 COST-EFFECTIVENESS OF CAPECITABINE IN COMBINATION WITH DOCETAXEL VERSUS DOCETAXEL MONOTHERAPY IN PATIENTS WITH ADVANCED AND/OR METASTATIC BREAST CANCER IN FRANCE

✍ Scribed by H Lilliu; C Le Pen; G Priol; K Perez-Niddam; R Aultman; L Garrison

Book ID: 119592528
Publisher: John Wiley and Sons
Year: 2003
Tongue: English
Weight: 63 KB
Volume: 6
Category: Article
ISSN: 1098-3015
DOI: 10.1016/s1098-3015(10)61606-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Capecitabine plus docetaxel combination

Capecitabine plus docetaxel combination therapy : Cost-effectiveness in patients with anthracycline-pretreated advanced breast carcinoma

✍ Shailendra Verma; Dominique Maraninchi; Joyce O'Shaughnessy; Carol Jamieson; Ste 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 120 KB 👁 1 views

Docetaxel/Capecitabine Shows a Survival

Docetaxel/Capecitabine Shows a Survival Advantage over Docetaxel Monotherapy in Patients with Anthracycline-Pretreated Metastatic Breast Cancer

📂 Article 📅 2001 🏛 CIG Media Group, LP. 🌐 English ⚖ 102 KB

Erlotinib in combination with capecitabi

Erlotinib in combination with capecitabine and docetaxel in patients with metastatic breast cancer: A dose-escalation study

✍ Chris Twelves; José M. Trigo; Rob Jones; Flavio De Rosa; Ashok Rakhit; Scott Fet 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 190 KB

Capecitabine in combination with docetax

Capecitabine in combination with docetaxel and epirubicin in patients with previously untreated, advanced breast carcinoma

✍ Marco Venturini; Antonio Durando; Ornella Garrone; Maria Antonietta Colozza; Ant 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 103 KB 👁 1 views

## Abstract ## BACKGROUND The objective of this study was to evaluate the activity and safety of oral capecitabine in combination with docetaxel and epirubicin (TEX) as first‐line treatment for patients with locally advanced/metastatic breast carcinoma. ## METHODS This open‐label, Phase II study

Neoadjuvant Docetaxel, Capecitabine and

Neoadjuvant Docetaxel, Capecitabine and Cisplatin (DXP) in Patients with Unresectable Locally Advanced or Metastatic Gastric Cancer

✍ Sun Jin Sym; Heung Moon Chang; Min-Hee Ryu; Jae-Lyun Lee; Tae Won Kim; Jeong Hwa 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 274 KB

Phase II Study of Weekly Docetaxel and C

Phase II Study of Weekly Docetaxel and Capecitabine in Patients with Metastatic Breast Cancer

✍ Ewa Mrozek; Bhuvaneswari Ramaswamy; Donn Young; Chris A. Rhoades; Kari Kendra; J 📂 Article 📅 2006 🏛 CIG Media Group, LP. 🌐 English ⚖ 111 KB